Volume | 507,604 |
|
|||||
News | - | ||||||
Day High | 67.34 | Low High |
|||||
Day Low | 66.97 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Axonics Inc | AXNX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
67.34 | 66.97 | 67.34 | 67.05 | 67.20 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
7,201 | 507,604 | US$ 67.19 | US$ 34,103,382 | - | 47.59 - 69.68 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:01:56 | 55 | US$ 67.05 | USD |
Axonics (AXNX) Options Flow Summary
Axonics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
3.42B | 51.00M | - | 366.38M | -6.09M | -0.12 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Axonics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AXNX Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 67.69 | 67.775 | 66.97 | 67.42 | 803,393 | -0.64 | -0.95% |
1 Month | 68.89 | 69.67 | 66.97 | 68.24 | 1,122,035 | -1.84 | -2.67% |
3 Months | 68.35 | 69.67 | 66.68 | 68.06 | 929,118 | -1.30 | -1.90% |
6 Months | 53.50 | 69.68 | 48.30 | 65.38 | 991,437 | 13.55 | 25.33% |
1 Year | 58.50 | 69.68 | 47.59 | 61.22 | 819,568 | 8.55 | 14.62% |
3 Years | 59.68 | 79.915 | 38.41 | 61.30 | 650,351 | 7.37 | 12.35% |
5 Years | 18.51 | 79.915 | 15.25 | 53.41 | 590,272 | 48.54 | 262.24% |
Axonics Description
Axonics Inc is a United stated based medical technology company. It focuses on the design, development, and commercialization of innovative and minimally invasive sacral neuromodulation (SNM) solutions. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention. The company has designed and developed the r-SNM System, which delivers mild electrical pulses to the targeted sacral nerve in order to restore normal communication to and from the brain to reduce the symptoms of overactive bladder and fecal incontinence. |